Having trouble accessing articles? Reset your cache.

Hydroxychloroquine: Phase I data

Data from the second dose cohort of the open-label, dose-escalation, U.S. Phase I HSO1 trial in patients with relapsed or

Read the full 208 word article

User Sign In

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE